The Dutch healthcare giant said that it also plans to invest in a service training program in Cleveland.
The healthcare business at Royal Philips (NYSE:PHG) said last week that it plans to shutter manufacturing operations at a Cleveland plant that makes computed tomography scanners as part of a $600 million R&D initiative.
The Dutch healthcare giant said Feb. 9 that it also plans to invest in a service training program in Cleveland. Manufacturing at the CT plant in Highland Heights, Ohio, which accounts for 3% of Philips’ imaging sales, is slated to shut down during the second half of the year, the company said. Philips plans to spends $600 million annually on its North American R&D programs.
